Medtronic reports first real-world data on smart insulin pen system
March 20, 2025
Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.
Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.
Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.
Synchron today unveiled its roadmap to Chiral, a foundation model of human cognitions for its brain-computer interface (BCI) platform.
A research team has successfully developed an innovative platform for diabetes treatment using bioink derived from pancreatic tissue and 3D bioprinting technology. This study was recently published online in Nature Communications. The team was led by Professor Jinah Jang at Pohang University of Science and Technology (POSTECH), along with Myungji Kim, a Ph.D. candidate.
Biomedical engineers at Georgia Tech have developed a system for collecting and processing thermal images that allows for reliable, detailed measurement of vital signs such as respiration and heart rate or body temperature.
The latest advance in wearable robotic technology promises to solve a 200-year-old problem by revolutionizing the fit of prosthetic limbs, transforming the lives of millions of amputees worldwide.
Researchers at the University of Houston, in collaboration with Baylor College of Medicine, are developing new devices for treating children with hyperleukocytosis, a condition that develops when the body has an extremely high number of white blood cells, often due to leukemia.
Monogram Technologies secured 510(k) clearance for its robotic knee replacement system
The body you inhabit is made up of lots of moving parts that need to communicate with each other.
Some of this communication – in the nervous system, for example – takes the form of bioelectrical signals that propagate through the body to trigger the appropriate response.
Moon Surgical announced today that it received FDA clearance for ScoPilot, a Nvidia-enabled platform for its Maestro surgical robot.